Relative influence of male and female genital morphology on paternity in the dung beetle Onthophagus taurus

Studies of fertilization success have demonstrated that maleeffects are often a strong and important source of variationin P₂ (the proportion of offspring that are fertilized by thesecond male to mate). More recently there has been emphasison female processes that occur during and after copulation thatmight bias the outcome of male-male interactions. Here we usedthe sterile male technique to evaluate whether female genitalmorphology influences the repeatability of P₂ when the samepair of male dung beetles, Onthophagus taurus, copulated witha series of full-sib females or unrelated females that wereall unrelated to the male pair. Repeatability estimates of measuresof female genital morphology showed that full-sib females variedless in their genital morphology than did unrelated females.Therefore, if female genital traits are an important sourceof variation in male fertilization success, P₂ should be morerepeatable across full-sib than unrelated females. Contraryto this prediction, we show that the repeatability of P₂ didnot differ between female groups. Moreover, specific dimensionsof the female genitalia (sclerotized vagina and bursa) did notcontribute significantly to variance in P₂. In contrast, maleeffects had consistent and repeatable influences on paternityacross females. These were partly explained by variation inthe morphology of male genital sclerites.     

A reliable method for northern blot analysis using synthetic oligonucleotide probes.

We have developed a method for using short (30-42 base pair) synthetic oligonucleotide DNA probes in Northern blot assays. The method involves labeling the probes to high specific activity, very stringent hybridization and wash conditions, and the presence of several inhibitors of nonspecific binding in the hybridization buffer. We have tested this method with several probes obtained from local and commercial sources. The results with every probe used were high signal-to-noise ratios in an exposure time range of 30 min to 7 days.     

COVID-19 in patients undergoing long-term dialysis in Ontario

BACKGROUND:Patients undergoing long-term dialysis may be at higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of associated disease and mortality. We aimed to describe the incidence, risk factors and outcomes for infection in these patients in Ontario, Canada.METHODS:We used linked data sets to compare disease characteristics and mortality between patients receiving long-term dialysis in Ontario who were diagnosed SARS-CoV-2 positive and those who did not acquire SARS-CoV-2 infection, between Mar. 12 and Aug. 20, 2020. We collected data on SARS-CoV-2 infection prospectively. We evaluated risk factors for infection and death using multivariable logistic regression analyses.RESULTS:During the study period, 187 (1.5%) of 12 501 patients undergoing dialysis were diagnosed with SARS-CoV-2 infection. Of those with SARS-CoV-2 infection, 117 (62.6%) were admitted to hospital and the case fatality rate was 28.3%. Significant predictors of infection included in-centre hemodialysis versus home dialysis (odds ratio [OR] 2.54, 95% confidence interval [CI] 1.59–4.05), living in a long-term care residence (OR 7.67, 95% CI 5.30–11.11), living in the Greater Toronto Area (OR 3.27, 95% CI 2.21–4.80), Black ethnicity (OR 3.05, 95% CI 1.95–4.77), Indian subcontinent ethnicity (OR 1.70, 95% CI 1.02–2.81), other non-White ethnicities (OR 2.03, 95% CI 1.38–2.97) and lower income quintiles (OR 1.82, 95% CI 1.15–2.89).INTERPRETATION:Patients undergoing long-term dialysis are at increased risk of SARS-CoV-2 infection and death from coronavirus disease 2019. Special attention should be paid to addressing risk factors for infection, and these patients should be prioritized for vaccination.

As of Aug. 20, 2020, in Ontario, Canada’s most populous province, almost 41 000 people had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19),¹ which represented 0.3% of the provincial population. Close to 2800 people had died, a case fatality rate of 6.8%.²Patients undergoing dialysis have high rates of comorbid conditions, are often older adults, have varying degrees of immunosuppression and are more likely to reside in long-term care, which puts them at risk of both acquiring SARS-CoV-2 and developing complicated disease.^3,4 Furthermore, in Ontario, those who receive in-centre hemodialysis typically have 3 treatments per week in outpatient units located in or affiliated with hospitals, and the consequent inability to fully self-isolate means that patients undergoing hemodialysis likely have an even higher risk of SARS-CoV-2 infection.^3,4 Recent studies support this but do not compare infection rates with those in the local population of patients not undergoing dialysis.^5–10 Several studies have reported SARS-CoV-2 infection in single or multicentre cohorts of patients undergoing dialysis,^5–10 but we are unaware of any that have identified risk factors for infection at the level of a large region. Some studies have found that patients with SARS-CoV-2 infection who are undergoing dialysis are at high risk of severe illness and death.^6–10